ArticleOncoTargets and therapy2019

Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma.

Jiaxin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.